November 25, 2025

AtriCure, Inc. (ATRC) Stock Analysis: Exploring a 36.9% Potential Upside for Investors

AtriCure, Inc. (NASDAQ: ATRC) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Mason, Ohio, AtriCure specializes in the development..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 124% Potential Upside in the Biotechnology Arena

Investors with an eye on the healthcare sector might find Mesoblast Limited (NASDAQ: MESO) intriguing, especially given its substantial growth potential. The Melbourne-based biotechnology company, known for its pioneering work..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Impressive Revenue Growth Amidst High Forward P/E

Arcutis Biotherapeutics, Inc. (ARQT) is making waves in the biotechnology sector with its focus on innovative treatments for dermatological diseases. Based in Westlake Village, California, this U.S.-based company has captured..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A 15.12% Potential Upside in the Healthcare Sector

Alphatec Holdings, Inc. (NYSE: ATEC), a prominent player in the medical devices industry, specializes in innovative technologies for the surgical treatment of spinal disorders. With a market capitalization of $3.06..

National HealthCare Corporation (NHC) Stock Analysis: A Steady Performer with 12.5% Revenue Growth in the Healthcare Sector

National HealthCare Corporation (NYSE: NHC) has established itself as a prominent player in the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of..

Denali Therapeutics (DNLI) Stock Analysis: A 69% Potential Upside in Neurodegenerative Treatment Innovations

Denali Therapeutics Inc. (NASDAQ: DNLI) is capturing the attention of investors with its innovative approach to treating neurodegenerative and lysosomal storage diseases. With a market capitalization of $2.78 billion, this..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 14.29% Upside Amidst Strong Revenue Growth

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, is garnering attention from investors due to its notable position in the medical devices industry. Headquartered in London, LivaNova’s..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring 144.79% Potential Upside in Biotech Innovation

Investors seeking opportunities within the burgeoning biotech sector might find Janux Therapeutics, Inc. (NASDAQ: JANX) particularly compelling. With a market capitalization of $1.9 billion, Janux is making strides in the..

HUTCHMED (China) Limited (HCM) Investor Outlook: Unpacking a 58.53% Potential Upside

HUTCHMED (China) Limited (HCM) represents a compelling opportunity for investors interested in the dynamic field of biotechnology and pharmaceuticals. With its specialization in developing and commercializing targeted therapeutics and immunotherapies,..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Exploring a Promising 13% Upside Potential in Biotechnology

In the dynamic world of biotechnology, Scholar Rock Holding Corporation (NASDAQ: SRRK) presents an intriguing opportunity for investors focused on innovation-driven growth. With a market capitalization of $4.26 billion, this..

Premier, Inc. (PINC) Stock Analysis: Exploring the 2.97% Dividend Yield Amidst Market Challenges

Investors eyeing the healthcare sector might want to take a closer look at Premier, Inc. (NASDAQ: PINC), a notable player in the health information services industry. With its headquarters in..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring the 20.82% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a stalwart in the healthcare sector with a focus on medical instruments and supplies, is currently drawing investor attention with a notable potential upside of..

Haemonetics Corporation (HAE) Stock Analysis: A Look at the 6.16% Potential Upside Amid Robust Analyst Support

Haemonetics Corporation (NYSE: HAE), a notable player in the healthcare sector, continues to attract investor interest with its innovative suite of medical technologies and a promising 6.16% potential upside based..

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook Reveals 34% Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is emerging as a notable player in the healthcare sector, particularly within the specialized drug manufacturing industry. Based in Rockville, Maryland, this biopharmaceutical company focuses..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unveiling a 374% Potential Upside with Strong Buy Ratings

ImmunityBio, Inc. (NASDAQ: IBRX) has emerged as a compelling player in the biotechnology sector, captivating investor attention with its robust potential upside of 374.42%. Headquartered in San Diego, California, ImmunityBio..

Certara, Inc. (CERT) Stock Analysis: Potential 49% Upside Beckons Healthcare Investors

Certara, Inc. (NASDAQ: CERT), a leader in the healthcare sector’s health information services industry, offers investors a compelling narrative as it navigates through the complexities of drug discovery and development...

Concentra Group Holdings Parent (CON) Stock Analysis: Uncovering a 38.54% Potential Upside

Concentra Group Holdings Parent, Inc. (CON) emerges as an intriguing prospect for investors eyeing the healthcare sector, particularly within the medical care facilities industry. Based in Addison, Texas, Concentra specializes..

Immunovant, Inc. (IMVT) Stock Analysis: A Biotech Gem with a 66% Upside Potential

Immunovant, Inc. (IMVT), a clinical-stage biotech firm, has recently captured the attention of investors seeking growth opportunities in the healthcare sector. With its focus on developing monoclonal antibodies for autoimmune..

Disc Medicine, Inc. (IRON) Stock Analysis: A Biotech Gem with a 23% Potential Upside

Disc Medicine, Inc. (NASDAQ: IRON) has caught the attention of individual investors, thanks to its robust performance metrics and promising future in the biotech sector. Headquartered in Watertown, Massachusetts, Disc..

Merus N.V. (MRUS) Stock Analysis: Biotechnology Innovator with a 1.09% Upside Potential

Merus N.V. (MRUS), a trailblazing name in the biotechnology sector, is currently making waves in the healthcare industry with its innovative approaches to antibody therapeutics. Headquartered in the Netherlands, this..

Search

Funds

November 25, 2025

Search

Funds

November 25, 2025

FTSE 100

Funds